- Home
- LICN vs ANIX Comparison
LICN vs ANIX Comparison
Compare LICN & ANIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LICN
- ANIX
- Stock Information
- Founded
- LICN 2004
- ANIX 1982
- Country
- LICN China
- ANIX United States
- Employees
- LICN N/A
- ANIX N/A
- Industry
- LICN
- ANIX Biotechnology: Pharmaceutical Preparations
- Sector
- LICN
- ANIX Health Care
- Exchange
- LICN Nasdaq
- ANIX Nasdaq
- Market Cap
- LICN 83.8M
- ANIX 91.7M
- IPO Year
- LICN 2023
- ANIX 1987
- Fundamental
- Price
- LICN $0.16
- ANIX $2.65
- Analyst Decision
- LICN
- ANIX Strong Buy
- Analyst Count
- LICN 0
- ANIX 2
- Target Price
- LICN N/A
- ANIX $8.50
- AVG Volume (30 Days)
- LICN 21.2M
- ANIX 101.3K
- Earning Date
- LICN 12-24-2024
- ANIX 01-14-2025
- Dividend Yield
- LICN N/A
- ANIX N/A
- EPS Growth
- LICN 36.90
- ANIX N/A
- EPS
- LICN 0.28
- ANIX N/A
- Revenue
- LICN $41,929,000.00
- ANIX N/A
- Revenue This Year
- LICN N/A
- ANIX N/A
- Revenue Next Year
- LICN N/A
- ANIX N/A
- P/E Ratio
- LICN $0.61
- ANIX N/A
- Revenue Growth
- LICN 24.86
- ANIX N/A
- 52 Week Low
- LICN $0.15
- ANIX $2.15
- 52 Week High
- LICN $2.44
- ANIX $5.13
- Technical
- Relative Strength Index (RSI)
- LICN 19.85
- ANIX 33.20
- Support Level
- LICN $0.15
- ANIX $2.80
- Resistance Level
- LICN $0.19
- ANIX $3.43
- Average True Range (ATR)
- LICN 0.23
- ANIX 0.18
- MACD
- LICN -0.13
- ANIX -0.04
- Stochastic Oscillator
- LICN 0.65
- ANIX 11.84
About LICN Lichen China Limited
Lichen China Ltd is a holding company. The company, along with its subsidiaries provides financial and taxation solution services; education support services; and software and maintenance services. The company generates Majority revenue from Financial and taxation solution services.
About ANIX Anixa Biosciences Inc.
Anixa Biosciences Inc, a cancer-focused biotechnology company, developing vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.